Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease
1 other identifier
observational
310
1 country
2
Brief Summary
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by pathologic intraneuronal alpha-synuclein-positive Lewy bodies and neuronal cell loss. The cardinal clinical symptoms and signs of PD are bradykinesia, rigidity, tremor, postural instability, and freezing attacks. The prevalence of PD increases with age, affecting 1-2% of the population over the age of 65 years, and 3% of those over 85 years. Restless legs syndrome (RLS) represents disturbing symptoms in lower limbs that lead to the urge to move, occurring in rest periods. Movements can partially or completely relieve these abnormal feelings. In 2014, the International RLS Study Group (IRLSSG) established five mandatory criteria for the diagnosis of RLS. Several studies supported that RLS and PD may share pathophysiological mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
May 15, 2025
May 1, 2025
1.9 years
November 10, 2024
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The prevalence of restless leg syndrome in patients with Parkinson's disease
At the time of recruitment
Secondary Outcomes (1)
Clinical characteristics of Parkinson's disease patients with restless leg syndrome
At the time of recruitment
Study Arms (1)
Patients with parkinson's disease
Interventions
The patients will be screened for restless leg syndrome by clinical questioning.
Eligibility Criteria
Patients with Parkinson's disease aged from 18 to 80 years who met the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria. The patients must regularly visit the movement disorders clinic at least 2 times per year.
You may qualify if:
- Patients with Parkinson's disease aged from 18 to 80 years who met the United Kingdom Parkinson's Disease Society (UKPDS) Brain Bank Diagnostic criteria.
You may not qualify if:
- Patients with atypical or secondary parkinsonism.
- Patients with Mini-mental status exam (MMSE) less than 24 of 30.
- Patients with secondary causes of restless leg syndrome including end-stage renal disease, iron deficiency anemia and pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Siriraj Hospitallead
Study Sites (2)
Siriraj Hospital, Mahidol University
Bangkok, Bangkok, 10700, Thailand
Siriraj Hospital, Mahidol University
Bangkok, Thailand, 10310, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jindapa Srikajon, Doctor of Medicine
Siriraj Sleep Center, Faculty of Medicine, Siriraj Hospital, Mahidol University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD.
Study Record Dates
First Submitted
November 10, 2024
First Posted
November 12, 2024
Study Start
December 1, 2024
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
May 15, 2025
Record last verified: 2025-05